Tami Roman was named an honorary member of Sigma Gamma Rho in a 21-woman class announced in Tampa, then answered criticism ...

Here are the Texas A&M players who gained or lost weight this offseason based on the latest 2026 roster measurements.

SAVANNAH, Ga. (WTOC) - One in 4 Americans have experienced being overweight, according to the CDC, 35 to 40% of Georgia residents are overweight, placing the state in the highest obesity category.

Share on Pinterest Could time-restricted eating lead to lasting weight loss? Image credit: RgStudio/ Getty Images Intermittent fasting is the practice of eating during specific time frames while ...

For 35 years, Barbara Senich only owned black pants. “I thought somehow, that would make me look less big,” said Senich, 69, who has struggled with obesity for most of her life. At her heaviest, ...

Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they ...

Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity. Lilly said people on the next-generation weight loss ...

Retatrutide, a powerful experimental weight-loss drug that mimics three different hormones the body produces after eating, helped people lose 70 pounds on average, or 28% of their body weight, ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins See more of our coverage in your search ...

Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...